Can Binding Sites Be Targeted for Antidote Development?
Yes, binding sites can be targeted for antidote development. By understanding the exact site and mechanism of toxin binding, researchers can design molecules that either block the toxin from binding or displace it if binding has already occurred. For example, chelating agents are used to treat heavy metal poisoning by binding to the metal ions and facilitating their excretion.
